Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Annovis Bio Inc
(NY:
ANVS
)
13.00
-0.11 (-0.84%)
Streaming Delayed Price
Updated: 9:48 AM EDT, Jul 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Annovis Bio Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
64 Biggest Movers From Friday
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Biotechs Ready To Roar
June 13, 2021
The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...
Via
Talk Markets
Exposures
Product Safety
Why Is Annovis Bio's Stock Surging Higher Today?
May 21, 2021
Annovis Bio Inc (NYSE:ANVS) shares are trading higher b...
Via
Benzinga
46 Stocks Moving In Friday's Mid-Day Session
June 11, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's Investments
June 11, 2021
Data doesn't lie. These companies have the potential to quickly steal the spotlight.
Via
The Motley Fool
Exposures
Product Safety
Annovis Bio to Present at 2021 BIO Digital
June 10, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 10, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
This Biotech Stock Is Up 884% In 2021, But It Could Go Even Higher
June 10, 2021
With updates from clinical trials expected as soon as this month, anything is possible.
Via
The Motley Fool
Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use?
June 08, 2021
Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.
Via
Investor's Business Daily
Annovis' Alzheimer's/Parkinson's Candidate Protects Nerve Cells Against Ill Effects of Higher Neurotoxic Proteins
June 08, 2021
Annovis Bio Inc (NYSE: ANVS) has announced preliminary data demonstrating that ANVS401 protects certain nerve cells from dying after being infected by gingipains, which...
Via
Benzinga
Annovis Bio Expands Potential Application of ANVS401 to Infectious Diseases with New Preclinical Study
June 08, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 8, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a...
Via
Newsfile
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
June 07, 2021
There are better options for investors looking to profit from potential Alzheimer's disease treatments.
Via
The Motley Fool
Exposures
Product Safety
Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab
June 07, 2021
The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.
Via
Investor's Business Daily
Exposures
Product Safety
Annovis Bio to Present at Jefferies Virtual Healthcare Conference 2021
June 03, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 3, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Annovis Bio's ANVS401 Improves Speed and Accuracy in Alzheimer's and in Parkinson's Patients
June 01, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - June 1, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's...
Via
Newsfile
Annovis Bio Engages Global Executive Search Leader Spencer Stuart to Expand its Board and Management Team
May 28, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - May 28, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Exposures
Product Safety
68 Biggest Movers From Yesterday
June 02, 2021
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached...
Via
Benzinga
Annovis Bio, Inc. Announces Closing of $50 Million Public Offering
May 27, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - May 27, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
54 Biggest Movers From Yesterday
May 26, 2021
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...
Via
Benzinga
22 Stocks Moving in Monday's Pre-Market Session
May 24, 2021
Gainers Virgin Galactic Holdings, Inc. (NYSE: SPCE) rose 29.3% to $27.25 in pre-market trading. Virgin Galactic’s VSS Unity spacecraft completed its first spaceflight from...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises
May 24, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones surged over 100 points in the previous session. Investors are awaiting earnings...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
48 Biggest Movers From Friday
May 24, 2021
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug...
Via
Benzinga
5 Stocks To Watch For May 24, 2021
May 24, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Nordson Corporation (NASDAQ: NDSN) to report quarterly earnings at $1.64 per share on revenue of $...
Via
Benzinga
Annovis Bio, Inc. Announces Pricing of Public Offering
May 23, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - May 23, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Annovis Bio, Inc. Announces Proposed Public Offering of Common Stock
May 21, 2021
Berwyn, Pennsylvania--(Newsfile Corp. - May 21, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug...
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Mid-Afternoon Market Update: Dow Rises 150 Points; VF Corp Shares Fall On Downbeat Earnings
May 21, 2021
Toward the end of trading Friday, the Dow traded up 0.44% to 34,234 while the NASDAQ fell 0.26% to 13,500.91. The S&P also rose, gaining 0.07% to 4,161.93. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Nasdaq Turns Lower; Annovis Bio Shares Surge
May 21, 2021
Midway through trading Friday, the Dow traded up 0.71% to 34,327.47 while the NASDAQ fell 0.12% to 13,520.12. The S&P also rose, gaining 0.35% to 4,173.78. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
30 Stocks Moving In Friday's Mid-Day Session
May 21, 2021
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares jumped 105.4% to $54.23 after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401,...
Via
Benzinga
Annovis Bio Stock Rockets As Alzheimer's Drug Tops Biogen, Cassava Sciences
May 21, 2021
Annovis Bio said Friday its experimental Alzheimer's and Parkinson's treatment improved cognition in less than a month, leading ANVS stock to soar.
Via
Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Deere Beats Q2 Estimates
May 21, 2021
Following the market opening Friday, the Dow traded up 0.84% to 34,370.30 while the NASDAQ rose 0.37% to 13,585.45. The S&P also rose, gaining 0.58% to 4,183.17. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Annovis Bio's Stock Trading Higher As Alzheimer's/Parkinson's Candidate Shows Cognitive Improvement
May 21, 2021
Annovis Bio Inc (NYSE: ANVS) has announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401, for Alzheimer's disease (AD),...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.